University of Maryland School of Medicine startup acquired

Standard

Living Pharma Inc., a cancer treatment startup out of the University of Maryland School of Medicine, has been acquired by Lentigen Technology, a life sciences company in Gaithersburg.

Financial terms were not disclosed.

Living Pharma is developing a cancer treatment that uses a patient’s own T-cells…

fromhttp://www.baltimoresun.com/business/bs-bz-living-pharma-20170724-story.html

Advertisements